4 completed, 3 recruiting, 2 terminated, 1 enrolling by invitation. 3 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Recruiting 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Frontotemporal Dementia, Behavioral Variant: new trials by email Literature Review of Frontotemporal Dementia, Behavioral Variant trials Research Report on Frontotemporal Dementia, Behavioral Variant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases Computer-based facial expression recognition task, Computerized affective task, UCLA Structured Insight Interview - Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease | Recruiting | Assistance Publique - Hôpitaux de Paris | 34 | 2026-04-01 | 2026-04-15 | |
| Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia Vortioxetine - Fronto-temporal Dementia, Fronto-temporal Lobar Dementia | Phase 2 | Recruiting | Johns Hopkins University | 50 | 2025-03-20 | 2026-03-09 |
| Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs. Schizophrenia Disorder, Frontotemporal Dementia, Behavioral Variant | Enrolling by invitation | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 150 | 2025-02-01 | 2025-12-11 | |
| Nabilone for Agitation in Frontotemporal Dementia Nabilone, Placebo - Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant | Phase 2 | Terminated | Simon Ducharme, MD | 3 | 2023-03-07 | 2026-07-28 |
| ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions Remote collection of passive and active data for 28 consecutive days - Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 44 | 2022-05-20 | 2026-09-17 | |
| A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach DISBAND protocol - Bipolar Disorder, Frontotemporal Dementia, Behavioral Variant | Not applicable | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 210 | 2021-05-19 | 2024-11-26 |
| Intranasal Insulin in Frontotemporal Dementia (FTD) Novolin-R insulin - Frontotemporal Dementia, Behavioral Variant | Phase 2 | Terminated | HealthPartners Institute | 3 | 2019-09-09 | 2023-10-27 |
| Voices Of Individuals: Challenges and Experiences Of bvFTD Telephone Interview - Frontotemporal Dementia, Frontotemporal Degeneration | Completed | University of Pennsylvania | 26 | 2019-06-26 | 2026-01-12 | |
| Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia F-18 AV 1451 - Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia | Phase 1 | Completed | Mayo Clinic | 81 | 2016-07-01 | 2025-11-21 |
| Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia transcranial direct current stimulation (tDCS) - Alzheimer's Disease, Frontotemporal Dementia, Behavioral Variant | Not applicable | Completed | IRCCS Centro San Giovanni di Dio Fatebenefratelli | 45 | 2015-06-08 | 2021-05-19 |
Pick Disease of the Brain (10) · Alzheimer Disease (4) · Frontotemporal Dementia (4) · Aphasia, Primary Progressive (2) · Bipolar Disorder (2) · Dementia (1) · Depressive Disorder, Major (1) · Frontotemporal Dementia With Motor Neuron Disease (1) · Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia (1) · Insulin Resistance (1) · Mental Disorders (1) · Neurodegenerative Diseases (1) · Psychomotor Agitation (1) · Schizophrenia (1)
Brain Diseases (10) · Central Nervous System Diseases (10) · Frontotemporal Lobar Degeneration (10) · Nervous System Diseases (10) · Neurocognitive Disorders (10) · Dementia (9) · Mental Disorders (9) · Neurodegenerative Diseases (7) · Frontotemporal Dementia (6) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Proteostasis Deficiencies (4) · TDP-43 Proteinopathies (4) · Tauopathies (4) · Aphasia (2)
Insulin (1) · Interviews as Topic (1) · Transcranial Direct Current Stimulation (1) · Vortioxetine (1) · nabilone (1)
Assistance Publique - Hôpitaux de Paris (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · HealthPartners Institute (1) · IRCCS Centro San Giovanni di Dio Fatebenefratelli (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Johns Hopkins University (1) · Mayo Clinic (1) · Simon Ducharme, MD (1) · University of Pennsylvania (1)
United States (4) · France (2) · Italy (2) · Canada (1) · Spain (1)
Christopher Morrow, MD (1) · Elio Scarpini, Professor (1) · Jill Owczarzak, PhD (1) · Keith A Josephs, M.D. (1) · Lori Erby, PhD, ScM (1) · Michael H Rosenbloom, MD (1) · Michela Pievani, PhD (1) · Richard Levy, MD, PhD (1)
K23AG088248 (1), R21NS094684 (1)